American International Group, Inc. Kronos Bio, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.34 - $2.62 $523 - $1,024	391 Added 2.03%	19,636 $28,000
Q4 2022 Feb 10, 2023	SELL	$1.44 - $3.44 $100 - $240	-70 Reduced 0.36%	19,245 $31,000
Q3 2022 Nov 14, 2022	BUY	$3.35 - $5.55 $914 - $1,515	273 Added 1.43%	19,315 $65,000
Q2 2022 Aug 12, 2022	SELL	$3.12 - $7.52 $720 - $1,737	-231 Reduced 1.2%	19,042 $69,000
Q1 2022 May 13, 2022	SELL	$6.26 - $14.42 $8,488 - $19,553	-1,356 Reduced 6.57%	19,273 $139,000
Q4 2021 Feb 11, 2022	SELL	$11.35 - $21.18 $7,014 - $13,089	-618 Reduced 2.91%	20,629 $280,000
Q3 2021 Nov 12, 2021	SELL	$18.17 - $24.7 $9,157 - $12,448	-504 Reduced 2.32%	21,247 $445,000
Q2 2021 Aug 13, 2021	BUY	$20.08 - $29.02 $262,586 - $379,494	13,077 Added 150.76%	21,751 $521,000
Q1 2021 May 07, 2021	BUY	$27.0 - $32.48 $4,860 - $5,846	180 Added 2.12%	8,674 $254,000
Q4 2020 Feb 12, 2021	BUY	$26.68 - $38.23 $226,619 - $324,725	8,494 New	8,494 $254,000

20.7M

31.4K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.